375 related articles for article (PubMed ID: 8805247)
1. Nonclassical HLA-G molecules are classical peptide presenters.
Diehl M; Münz C; Keilholz W; Stevanović S; Holmes N; Loke YW; Rammensee HG
Curr Biol; 1996 Mar; 6(3):305-14. PubMed ID: 8805247
[TBL] [Abstract][Full Text] [Related]
2. Peptide presentation and NK inhibition by HLA-G.
Münz C; Stevanović S; Rammensee HG
J Reprod Immunol; 1999 Jul; 43(2):139-55. PubMed ID: 10479050
[TBL] [Abstract][Full Text] [Related]
3. HLA non-A,B,C class I genes: their structure and expression.
Heinrichs H; Orr HT
Immunol Res; 1990; 9(4):265-74. PubMed ID: 2089074
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface.
Clements CS; Kjer-Nielsen L; Kostenko L; Hoare HL; Dunstone MA; Moses E; Freed K; Brooks AG; Rossjohn J; McCluskey J
Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3360-5. PubMed ID: 15718280
[TBL] [Abstract][Full Text] [Related]
5. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G.
O'Callaghan CA; Bell JI
Immunol Rev; 1998 Jun; 163():129-38. PubMed ID: 9700506
[TBL] [Abstract][Full Text] [Related]
6. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells.
Münz C; Holmes N; King A; Loke YW; Colonna M; Schild H; Rammensee HG
J Exp Med; 1997 Feb; 185(3):385-91. PubMed ID: 9053439
[TBL] [Abstract][Full Text] [Related]
7. Classical and nonclassical class I major histocompatibility complex molecules exhibit subtle conformational differences that affect binding to CD8alphaalpha.
Gao GF; Willcox BE; Wyer JR; Boulter JM; O'Callaghan CA; Maenaka K; Stuart DI; Jones EY; Van Der Merwe PA; Bell JI; Jakobsen BK
J Biol Chem; 2000 May; 275(20):15232-8. PubMed ID: 10809759
[TBL] [Abstract][Full Text] [Related]
8. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association.
Lee N; Malacko AR; Ishitani A; Chen MC; Bajorath J; Marquardt H; Geraghty DE
Immunity; 1995 Nov; 3(5):591-600. PubMed ID: 7584149
[TBL] [Abstract][Full Text] [Related]
9. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.
Borrego F; Ulbrecht M; Weiss EH; Coligan JE; Brooks AG
J Exp Med; 1998 Mar; 187(5):813-8. PubMed ID: 9480992
[TBL] [Abstract][Full Text] [Related]
10. Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices.
Di Marco M; Schuster H; Backert L; Ghosh M; Rammensee HG; Stevanović S
J Immunol; 2017 Oct; 199(8):2639-2651. PubMed ID: 28904123
[TBL] [Abstract][Full Text] [Related]
11. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition.
Ishitani A; Sageshima N; Lee N; Dorofeeva N; Hatake K; Marquardt H; Geraghty DE
J Immunol; 2003 Aug; 171(3):1376-84. PubMed ID: 12874228
[TBL] [Abstract][Full Text] [Related]
12. A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.
Lorente E; Infantes S; Abia D; Barnea E; Beer I; García R; Lasala F; Jiménez M; Mir C; Morreale A; Admon A; López D
J Biol Chem; 2012 Oct; 287(42):34895-34903. PubMed ID: 22927436
[TBL] [Abstract][Full Text] [Related]
13. Pocketcheck: updating the HLA class I peptide specificity roadmap.
Huyton T; Ladas N; Schumacher H; Blasczyk R; Bade-Doeding C
Tissue Antigens; 2012 Sep; 80(3):239-48. PubMed ID: 22803829
[TBL] [Abstract][Full Text] [Related]
14. Requirement of the proteasome for the trimming of signal peptide-derived epitopes presented by the nonclassical major histocompatibility complex class I molecule HLA-E.
Bland FA; Lemberg MK; McMichael AJ; Martoglio B; Braud VM
J Biol Chem; 2003 Sep; 278(36):33747-52. PubMed ID: 12821659
[TBL] [Abstract][Full Text] [Related]
15. HLA-A2 subtypes are functionally distinct in peptide binding and presentation.
Barouch D; Friede T; Stevanović S; Tussey L; Smith K; Rowland-Jones S; Braud V; McMichael A; Rammensee HG
J Exp Med; 1995 Dec; 182(6):1847-56. PubMed ID: 7500030
[TBL] [Abstract][Full Text] [Related]
16. Human T cell receptor-mediated recognition of HLA-E.
García P; Llano M; de Heredia AB; Willberg CB; Caparrós E; Aparicio P; Braud VM; López-Botet M
Eur J Immunol; 2002 Apr; 32(4):936-44. PubMed ID: 11920559
[TBL] [Abstract][Full Text] [Related]
17. Large scale mass spectrometric profiling of peptides eluted from HLA molecules reveals N-terminal-extended peptide motifs.
Escobar H; Crockett DK; Reyes-Vargas E; Baena A; Rockwood AL; Jensen PE; Delgado JC
J Immunol; 2008 Oct; 181(7):4874-82. PubMed ID: 18802091
[TBL] [Abstract][Full Text] [Related]
18. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells.
Crew MD; Cannon MJ; Phanavanh B; Garcia-Borges CN
Mol Immunol; 2005 Jun; 42(10):1205-14. PubMed ID: 15829309
[TBL] [Abstract][Full Text] [Related]
19. Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach.
Stevens J; Joly E; Trowsdale J; Butcher GW
BMC Immunol; 2001; 2():5. PubMed ID: 11432755
[TBL] [Abstract][Full Text] [Related]
20. Interaction of HLA-E with peptides and the peptide transporter in vitro: implications for its function in antigen presentation.
Ulbrecht M; Modrow S; Srivastava R; Peterson PA; Weiss EH
J Immunol; 1998 May; 160(9):4375-85. PubMed ID: 9574542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
